643.00
+8.00
+(1.26%)
At close: January 31 at 5:38:37 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-420,327.00
-862,807.00
-606,812.00
-398,463.00
Investing Cash Flow
--
308,210.00
-461,184.00
-347,070.00
344,692.00
Financing Cash Flow
--
1,336,727.00
843,757.00
1,121,342.00
833,003.00
End Cash Position
--
2,048,844.00
800,740.00
1,334,676.00
1,216,803.00
Capital Expenditure
--
-43,812.00
-103,823.00
-121,434.00
-5,139.00
Issuance of Capital Stock
--
1,196,731.00
760,953.00
1,091,326.00
813,186.00
Repayment of Debt
--
-3,801.00
-4,165.00
-3,855.00
-2,550.00
Free Cash Flow
--
-464,139.00
-966,630.00
-728,246.00
-403,602.00
12/31/2020 - 7/10/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
UCB.BR UCB SA
188.20
-0.61%
TUB.BR Financière de Tubize SA
152.80
-0.26%
ONWD.BR Onward Medical N.V.
6.36
+0.95%
GLPG.AS Galapagos NV
22.16
-0.09%
ASND Ascendis Pharma A/S
130.66
+2.64%
BIOS.BR BioSenic S.A.
0.0036
0.00%
CYAD.BR Celyad Oncology SA
0.4300
-4.34%
PHARM.AS Pharming Group N.V.
0.8660
+0.12%
ABVX ABIVAX Société Anonyme
5.97
+1.19%
TCRX TScan Therapeutics, Inc.
2.5700
-0.39%